<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - J&J Will Enroll 60,000 COVID-19 Vaccine Trial Participants
Image Overlay - J&J Will Enroll 60,000 COVID-19 Vaccine Trial Participants

J&J Will Enroll 60,000 COVID-19 Vaccine Trial Participants

J&J Will Enroll 60,000 COVID-19 Vaccine Trial Participants

Johnson & Johnson will enroll 60,000 trial participants in COVID-19 clinical trials. The company has said it will know if the vaccine is effective by the end of this year. The vaccine is differentiated from competitors because it requires only one dose instead of two and will not require freezing. The trials will take place in the United States, Argentina, Brazil, Chile, Colombia, Mexico, Peru, and South Africa. Yourway has a global presence and depots located around the world – because of our over 20 strategically located depot facilities, we get your clinical materials around the world in hours, not days.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat
Come chat with us!
Hello! How can I help you?